Thursday, January 24, 2013

    "The War In Medicine"

    Continued from previous post of

    The people on Sloan-Kettering's Board of Directors were a "Who's Who"
of investors in petrochemical and other polluting industries. In other
words, the hospital was being run by people who made their wealth by
investing in the worst cancer-causing things on the planet.

    CEOs of top pharmaceutical companies that produced cancer drugs also
dominated the Board. They had an obvious vested interest in promoting
chemotherapy and undermining natural therapies.

    The Chairman and the President of Bristol-Myers Squibb, the world's
leading producer of chemotherapy, held high positions on MSKCC's Board.

    Of the nine members of the Hospital's powerful Institutional Policy
Committee, seven had ties to the pharmaceutical industry

    The Hospital itself invested in the stock of these same drug

    Directors of the biggest tobacco companies in the U.S., Phillip
Morris and RJR Nabisco, held places of honor on the Board.

    Six Board Directors also served on the Boards of The New York Times,
CBS, Warner Communications, Readers Digest, and other media giants.

    Not surprisingly, profits from chemotherapy drugs were skyrocketing
and the media glowingly promoted every new drug as a "breakthrough" in
cancer. I kept all my notes in my filing cabinet at work. I had no idea
what I would ever do with them. I just knew that I had to get to the
bottom of it, for myself.

    Meanwhile, the public's interest in laetrile refused to go away. A
lot of people were going across the border to Mexican clinics to get the
stuff and my secretary's phone was ringing off the hook with people
wanting to know what Sloan-Kettering thought of its value. I was once
again told to give out the news that the studies had all been negative.

    At home, I called my family together for a meeting. With their
support, I decided I couldn't lie on behalf of the Hospital. In November
of 1977, I stood up at a press conference and blew the whistle on
Memorial Sloan Kettering Cancer Center's suppression of positive results
with amygdalin. It felt like jumping off the highest diving board, but I
had no doubt I was doing the right thing. I was fired the next day for
"failing to carry out his most basic responsibilities" as the Hospital

described it to the New York Times. In other words, failing to lie to the
American people.

    When I tried to pick up my things in my office, I found my files had
been padlocked and two armed Hospital guards escorted me from the

    Luckily for all of us, I have a very smart wife who all along had
been making copies of my research notes and had put a complete extra set
of files in a safe place. Those notes turned into my first book, The
Cancer Industry, which is still in print (in an updated version) and
available in bookstores.

    That dramatic day, when I stood up in front of the packed press
conference and told the truth, was the beginning of a journey I never
could have predicted. I was launched on a mission that I'm still on today
- helping cancer patients find the truth about the best cancer

    Well, we weren't able to buy a home until years later, the kids went
to colleges on scholarships and loans, and my wife took on a demanding
full-time job to help us get by. But in retrospect, my experiences as an

insider in "the cancer industry" were among the best things ever to
happen to me. My values were put to the test and I had to really examine
what was important in my life. It is because of this difficult experience
at Sloan-Kettering that I found a truly meaningful direction for my
professional life, rather than just climbing Sloan-Kettering's career
ladder and losing my soul in the process."
    Ralph Moss, author

Taken From:
The story of Ralph Moss, which is really the story of Dr. Kanematsu
Sugiura, is just the tip of the iceberg. Numerous alternative cancer
researchers have been rewarded for their discoveries with jail, being
driven out of the country, loss of license, harassment, and many other
things. This war is not for the weak at heart.

Copyright (c) 2003 R. Webster Kehr, all rights reserved

No comments:

Post a Comment